Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-22-015038
Filing Date
2022-06-16
Accepted
2022-06-16 21:49:49
Documents
2
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 7095
2 POWER OF ATTORNEY exhibit24-1.htm EX-24.1 827758
  Complete submission text file 0001062993-22-015038.txt   836386
Mailing Address NUTRITION 21 INC 4 MANHATTANVILLE ROAD PURCHASE NY 10577
Business Address
COOPER WARREN D (Reporting) CIK: 0001213897 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37526 | Film No.: 221022288

Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Issuer) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations